“The discovery of the 2009 H1N1 influenza pandemic and the emergence of other diseases such as SARS have highlighted the important role that diagnostic tools can play in improving the surveillance of infectious disease threats at the population level. Experiences with these events have shown that recognition of outbreaks, management of epidemics, and development of countermeasures can depend heavily on having access to highly specific surveillance information that is typically obtained from testing clinical specimens. Consequently, the rising threat of emerging diseases and concern about biological weapons has led to an emphasis in governments on improving laboratory and diagnostic capacity in order to improve global biosurveillance for infectious diseases.”
Executive Summary: Diagnostics for Global Biosurveillance
- February 10, 2012
- | Filed under North America, Other, Report, and 2001-2025
